logo dark logoo light logo
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Board of Directors
    • SEC Filings
    • Investor FAQ
  • About Us
    • About Us
    • Meet the Team
  • News
  • Contact
logo dark logoo light logo
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Board of Directors
    • SEC Filings
    • Investor FAQ
  • About Us
    • About Us
    • Meet the Team
  • News
  • Contact
mobile logo
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Board of Directors
    • SEC Filings
    • Investor FAQ
  • About Us
    • About Us
    • Meet the Team
  • News
  • Contact
ProLung Test is honored as “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global Health & Pharma
In Awards and Recognition, News

ProLung has been awarded the “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global...

Read More
In Their Words: Jared Bauer
In Awards and Recognition, News

In Their Words: Jared Bauer Utah has an incredibly strong life sciences community with a rich...

Read More
ProLung Test Granted ‘Breakthrough Device’ Designation by the FDA
In Awards and Recognition, News

ProLung Test Granted ‘Breakthrough Device’ Designation by the FDA Salt Lake City, UT, February 13, 2020...

Read More
ProLung Announces End of 2012-2014 Governance Issues
In News

ProLung Announces End of 2012-2014 Governance Issues Salt Lake City, UT, February 13, 2020 – ProLung,...

Read More
CEO Today Magazine Honors ProLung CEO Jared Bauer for Leadership and Strategic Vision in 2019
In Awards and Recognition, News

We are delighted to share that Jared Bauer, ProLung CEO, has been honored for his...

Read More
ProLung Announces Change to its Board of Directors
In News

ProLung Announces Change to its Board of Directors Salt Lake City, UT, November 26, 2019 –...

Read More
ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance at ISRD & ATS joint medical conference
In News

ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer...

Read More
ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity
In News

ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 73% specificity Salt Lake...

Read More
ProLung Promotes Jared Bauer from interim CEO to CEO
In News

ProLung Promotes Jared Bauer from interim CEO to CEO Salt Lake City, UT, October 2, 2019...

Read More
ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors
In News

ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of...

Read More
ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by Insights Success Magazine – ProLung, Inc.
In Awards and Recognition, News

ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by...

Read More
ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc.
In News

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech...

Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Categories

  • Awards and Recognition
  • News
  • Uncategorized

Search

Latest News

  • IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’ 05/10/2022
  • IONIQ hosts Salt Lake City Mayor Mendenhall at its Office 05/05/2022
  • IONIQ Sciences hires Edison Group as Investor Relations Advisor 03/16/2022

Archive

  • May 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • May 2020
  • April 2020
  • February 2020
  • January 2020
  • November 2019
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • March 2019
  • February 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • December 2017
  • May 2017
cancer testing modernized

Not available for sale in the USA

Latest News

  • IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’
  • IONIQ hosts Salt Lake City Mayor Mendenhall at its Office
  • IONIQ Sciences hires Edison Group as Investor Relations Advisor
  • IONIQ Sciences announces IP acquisition and License buyout

Twitter Feed

  • IONIQ is humbled to be recognized with 3 awards from Global 100. These awards and FDA 'Breakthrough Device' designa… https://t.co/qHhsVkMt8b
    1 week ago
  • For #LungCancer Hope Month, @LUNGevity, a leading patient advocacy group, is asking "what gives us hope?" We find h… https://t.co/hWuDCBg1gm
    2 weeks ago
  • We've hired Edison Group to assist with our investor relations program. Edison Group is a leading investor relation… https://t.co/mLhupu9MEp
    2 months ago

Subscribe to our Newsletter

ProLung, Inc. dba IONIQ Sciences Copyright 2020. All Rights Reserved - Privacy Policy - Terms and Conditions